Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
Goal attainment in cognitive rehabilitation in MS patients.
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger than Age 18 Years.
Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
[Acute transverse myelitis after allogeneic bone marrow transplantation for acute lymphoblastic leukemia--a case report].
Temporal aspects of visual perception in demyelinative diseases.
Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.
Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple Sclerosis.
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS).
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis.
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases.
Heavy metals, organic solvents and multiple sclerosis: an exploratory look at gene-environment interactions.
Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis.
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis.

Pages